archTIS Ltd has delivered a robust first quarter of the 2025 financial year, reporting notable sales growth, steady gross margins and disciplined cost management.
Pantoro Ltd (ASX:PNR, OTC:PNTOF) will focus on unlocking the full potential of the Norseman Gold Project after entering a binding agreement for the sale of the Halls Creek Project in Western Australia to Kimberley Minerals Group Pty Ltd (KMG) for $8 million.
Proceeds from the sale will bolster the financial position of Pantoro as it expands operations and production capacity at Norseman.
EnWave Corp (TSX-V:ENW, OTC:NWVCF) is transforming the food manufacturing industry with its innovative dehydration technology, which combines vacuum and microwave energy to dry foods and plants more efficiently and to a higher quality.
The company’s Radiant Energy Vacuum (REV) technology has been successfully commercialized across multiple verticals within the food industry, including dairy, fruit and vegetable, baked goods, meats, seafood, and pet treats.
Small-cap investors and companies listed on London’s AIM junior stock market exhaled a sigh of relief following Chancellor Rachel Reeves’ Autumn Statement, albeit that sigh was only half as enthusiastic as it could have been.
Reeves confirmed that an inheritance tax exemption on AIM investments will remain, although that exemption will be slashed in half.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has reported positive results from a preclinical study evaluating the combination of its lead development candidate intranasal foralumab and semaglutide, which is marketed by Novo Nordisk (NYSE:NVO) under the brand names Ozempic and Wegovy.
The study demonstrated that this combination effectively promotes liver homeostasis and reduces inflammation in preclinical models of diet-induced obesity.
OKYO Pharma Ltd (NASDAQ:OKYO) announced it will present at the 10th International Tear Film & Ocular Surface Society (TFOS) Conference in Venice, Italy, being held from October 30 to November 2.
Dr Raj Patil, OKYO’s chief scientific officer, will present efficacy and safety data from the Phase 2 trial of OK-101, OKYO’s leading candidate for treating dry eye disease (DED), on November 2.
Rome Resources’ Bisie North tin project in the DRC is close to a C$1 billion play in Alphamin and shares many characteristics including its original geologists, notes broker Oak Securities.
Drilling is underway to establish an initial resource at Bisie North, but it is the proximity to Alphamin’s operations and the involvement of Alphamin’s original discovery team that catches the eye, says Oak.
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) told investors it has completed its acquisition of operated natural gas assets in East Texas, for a gross headline figure of $69 million.
The net price, after adjustments, was confirmed by the company as $49 million.
Bradda Head Lithium Ltd (AIM:BHL, OTC:BHLIF, TSX-V:BHLI) has started reworking a new metallurgical particle sorting study on the composite samples collected in 2023 from San Domingo drill core using novel AI-based techniques.
The purpose of this new test-work plan, which builds on earlier metallurgical work in 2023, is to move Bradda Head closer to a potential production decision later in 2025, said the statement.
Helix Exploration PLC (AIM:HEX) has started drilling the Darwin-1 well at its Rudyard project, in Montana.
The drill operation is targeting ‘stacked’ reservoir structures within the Souris River and Dry Creek intervals, both of which are known for their helium potential.
Aeris Resources Ltd (ASX:AIS, OTC:ARSRF) recorded another good quarter at its Australian operations with copper equivalent production of 10,200 tonnes for the quarter, including 6,000 tonnes of copper, 15,200 ounces of gold and 43,900 ounces of silver.
While September quarter copper equivalent production was on par with the previous quarter, the AISC improved to A$5.32 per pound, down from $5.45.